- Fund Type: SICAV
- Objective: Region Fund-European
- Asset Class: Equity
- Geographic Focus: European Region
Invesco Pan European Equity Fund
+ Add to WatchlistINVPEGB:LX
12.66 EUR 0.01 0.08%As of 14:12:29 ET on 05/21/2013.
Snapshot for Invesco Pan European Equity Fund (INVPEGB)
| Year To Date: | +14.67% | 3-Month: | +11.25% | 3-Year: | +13.18% | 52-Week Range: | 8.89 - 12.66 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +10.18% | 1-Year: | +37.76% | 5-Year: | +3.02% | Beta vs FTWLEURO: | 0.97 |
Fund Profile & Information for INVPEGB
Invesco Pan European Equity Fund is a SICAV incorporated in Luxembourg. The Fund's objective is to provide long-term capital growth. The Fund invests primarily in a portfolio of equities of European companies, including the United Kingdom, with an emphasis on larger companies with above-average growth prospects. The Fund has no predetermined policy on geographical weighting.
| Inception Date: | 01-04-1999 | Telephone: | - |
|---|---|---|---|
| Managers: | JOHN SURPLICE / MARTIN WALKER | ||
| Web Site: | www.invesco.com | ||
Fundamentals for INVPEGB
| NAV | (on 2013-05-21) 12.66 |
|---|---|
| Assets (M) | (on 2013-05-21) 949.88 |
| Fund Leveraged | N |
| Minimum Investment | 1,500.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for INVPEGB
No dividends reported
Fees & Expenses for INVPEGB
| Front Load | 0.00 |
|---|---|
| Back Load | 4.00 |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | 4.00 |
| 12b1 Fee | - |
| Expense Ratio | 2.93 |
Top Fund Holdings for INVPEGB
Filing Date: 08/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Novartis AG | 695,707 | 32,689,565 | 4.969% |
| Roche Holding AG | 158,223 | 23,090,792 | 3.510% |
| BT Group PLC | 6,649,246 | 18,428,700 | 2.801% |
| ING Groep NV | 2,816,203 | 17,067,598 | 2.594% |
| Obrascon Huarte Lain SA | 903,712 | 15,313,400 | 2.328% |
| Cie Generale des Etablissement | 258,118 | 14,850,819 | 2.257% |
| Banco Bilbao Vizcaya Argentari | 2,522,257 | 14,843,482 | 2.256% |
| UBS AG | 1,645,868 | 14,754,355 | 2.243% |
| GlaxoSmithKline PLC | 810,491 | 14,735,698 | 2.240% |
| Deutsche Boerse AG | 355,564 | 14,636,792 | 2.225% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page